Pediatric essential thrombocythemia (ET) from the Czech Republic.
作者信息
Samuelson Scott J, Prchal Josef T
出版信息
Leuk Res. 2008 Mar;32(3):367-8. doi: 10.1016/j.leukres.2007.07.025. Epub 2007 Sep 7.
Abstract
摘要
相似文献
1
Pediatric essential thrombocythemia (ET) from the Czech Republic.来自捷克共和国的小儿原发性血小板增多症（ET）。
Leuk Res. 2008 Mar;32(3):367-8. doi: 10.1016/j.leukres.2007.07.025. Epub 2007 Sep 7.
2
Essential thrombocythemia with Mpl W515 K mutation in a child presenting with Budd-Chiari syndrome.一名患有布加综合征的儿童出现伴有Mpl W515 K突变的原发性血小板增多症。
Platelets. 2015;26(8):805-8. doi: 10.3109/09537104.2015.1041900. Epub 2015 May 13.
3
A rare CALR variant mutation and a review of CALR in essential thrombocythemia.CALR 罕见变异突变及 CALR 在原发性血小板增多症中的作用综述
J Thromb Thrombolysis. 2018 Apr;45(3):457-462. doi: 10.1007/s11239-018-1619-0.
4
Frequency and clinical features of the JAK2 V617F mutation in pediatric patients with sporadic essential thrombocythemia.散发性原发性血小板增多症患儿JAK2 V617F突变的频率及临床特征
Pediatr Blood Cancer. 2008 Dec;51(6):802-5. doi: 10.1002/pbc.21730.
5
Two faces of ET: CALR and JAK2.ET 的两面：CALR 和 JAK2。
Blood. 2014 Mar 6;123(10):1438-40. doi: 10.1182/blood-2014-01-547596.
6
CALR mutations in patients with essential thrombocythemia diagnosed in childhood and adolescence.儿童和青少年期诊断的原发性血小板增多症患者中的CALR突变
Blood. 2014 Jun 5;123(23):3677-9. doi: 10.1182/blood-2014-04-572040.
7
JAK2 V617F and MPL W515L/K mutations in Korean patients with essential thrombocythemia.韩国原发性血小板增多症患者中的JAK2 V617F和MPL W515L/K突变
Korean J Lab Med. 2010 Oct;30(5):474-6. doi: 10.3343/kjlm.2010.30.5.474.
8
MPL-mutated essential thrombocythemia: a morphologic reappraisal.MPL 突变的原发性血小板增多症：形态学再评估
Blood Cancer J. 2018 Nov 20;8(12):121. doi: 10.1038/s41408-018-0159-3.
9
[Essential thrombocythemia: molecular pathophysiology and treatment].[原发性血小板增多症：分子病理生理学与治疗]
Nihon Rinsho. 2012 Apr;70 Suppl 2:326-9.
10
MPL W515L mutation in pediatric essential thrombocythemia.MPL W515L 突变与儿童特发性血小板增多症。
Pediatr Blood Cancer. 2013 Aug;60(8):E52-4. doi: 10.1002/pbc.24500. Epub 2013 Feb 25.
本文引用的文献
1
Extending Jak2V617F and MplW515 mutation analysis to single hematopoietic colonies and B and T lymphocytes.将Jak2V617F和MplW515突变分析扩展至单个造血集落以及B淋巴细胞和T淋巴细胞。
Stem Cells. 2007 Sep;25(9):2358-62. doi: 10.1634/stemcells.2007-0175. Epub 2007 May 31.
2
Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia.真性红细胞增多症或原发性血小板增多症患者中纯合子JAK2 617V>F突变的临床特征。
Blood. 2007 Aug 1;110(3):840-6. doi: 10.1182/blood-2006-12-064287. Epub 2007 Mar 22.
3
In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele.真性红细胞增多症患者红系祖细胞的体外扩增导致JAK2 V617F等位基因减少。
Exp Hematol. 2007 Apr;35(4):587-95. doi: 10.1016/j.exphem.2006.12.007.
4
Polycythemia vera is not initiated by JAK2V617F mutation.真性红细胞增多症并非由JAK2V617F突变引发。
Exp Hematol. 2007 Jan;35(1):32-8. doi: 10.1016/j.exphem.2006.11.012.
5
Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia.V617F 突变纯合子祖细胞出现在大多数真性红细胞增多症患者中，但原发性血小板增多症患者中则不存在。
Blood. 2006 Oct 1;108(7):2435-7. doi: 10.1182/blood-2006-04-018259. Epub 2006 Jun 13.
6
Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera.
Exp Hematol. 2002 Mar;30(3):229-36. doi: 10.1016/s0301-472x(01)00789-5.
7
Zotero 插件